MAPK3 and prostate carcinoma: Otherwise, SHBG has been found to inhibit MCF-7 breast cancer cells growth via the direct blockade of ERK1/2 factors, while it has been demonstrated to stimulate the proliferation of the prostate cancer cell line, ALVA-41throught the increase in intracellular cAMP levels [30].